SCHEMBL1663817

SCHEMBL1663817

CCC[C@@H]1C(C(=O)OC)=C(C)NC(C)=C1C(=O)OCC

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.87
ALDH1A1 P00352 3/20 0.87
HSD17B10 Q99714 3/20 0.87
TP53 P04637 2/20 0.87
HPGD P15428 2/20 0.87
TSHR P16473 2/20 0.87
SMN1; SMN2 Q16637 1/20 0.57
ADORA3 P0DMS8 7/20 0.57
KDM4E B2RXH2 4/20 0.57
GAA P10253 3/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 2/20 0.51
HTT P42858 2/20 0.51
CYP2C9 P11712 3/20 0.50
MEN1 O00255 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C19 P33261 2/20 0.50
KMT2A Q03164 2/20 0.50
HIF1A Q16665 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9139821 0.93 ALDH1A1 (1.00) LMNAALDH1A1HSD17B10TP53HPGD
SCHEMBL11292115 0.93 TSHR (0.74) LMNAALDH1A1HSD17B10TP53HPGD
SCHEMBL9831538 0.91 LMNA (0.71) LMNAALDH1A1HSD17B10TP53HPGD
SCHEMBL7107070 0.89 LMNA (0.69) LMNAALDH1A1HSD17B10TP53HPGD
SCHEMBL17367963 0.87 ALDH1A1 (0.87) LMNAALDH1A1HSD17B10TP53HPGD
SCHEMBL9671967 0.87 ALDH1A1 (0.87) LMNAALDH1A1HSD17B10TP53HPGD
SCHEMBL1007130 0.83 ALDH1A1 (0.73) LMNAALDH1A1HSD17B10TP53HPGD
SCHEMBL7148358 0.82 ALDH1A1 (0.58) LMNAALDH1A1HSD17B10TP53HPGD
SCHEMBL7152871 0.82 ALDH1A1 (0.78) LMNAALDH1A1HSD17B10TP53HPGD
SCHEMBL8106730 0.81 KDM4E (0.86) LMNAALDH1A1HSD17B10TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2311806-A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists The United States of America, Represented by the Secretary, Department of Health and Human Services (US) 2011-04-20 EP disclosed
US-6066642-A FOR SELECTIVELY BLOCKING THE A3 ADENOSINE RECEPTOR OF A MAMMAL THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-05-23 US disclosed